Healthequity, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Delano Ladd, EVP, General Counsel of Healthequity, Inc., reported a transaction in 1,080 shares of common stock on October 6, 2026.
NASDAQ
Michael Henry Fiore, Former EVP, CCO of Healthequity, Inc., reported a transaction in 2,032 shares of common stock on October 6, 2026.
NASDAQ
Stephen Neeleman, FOUNDER AND VICE CHAIRMAN and a Director of Healthequity, Inc., reported a transaction in 1,095 shares of common stock on October 6, 2026.
NASDAQ
Michael Gathright, Chief Customer Officer of Healthequity, Inc., reported a transaction in 662 shares of common stock on October 6, 2026.
NASDAQ
James M Lucania, EVP & CFO of Healthequity, Inc., reported a transaction in 2,822 shares of common stock on October 6, 2026.
NASDAQ
Scott Cutler, President and CEO and a Director of Healthequity, Inc., reported a transaction in 1,230 shares of common stock on October 6, 2026.
NASDAQ
Stephen Neeleman, FOUNDER AND VICE CHAIRMAN and a Director of Healthequity, Inc., reported a transaction in 1,500 shares of common stock on September 17, 2026.
NASDAQ
Adrian T Dillon, a Director of Healthequity, Inc., sold 7,632 shares of common stock on August 25, 2026.
NASDAQ
Michael Henry Fiore, EVP, CHIEF COMMERCIAL OFFICER of Healthequity, Inc., sold 2,354 shares of common stock on July 10, 2026 for $95.00 per share.
NASDAQ
Michael Gathright, Chief Customer Officer of Healthequity, Inc., reported a transaction in 2,270 shares of common stock on July 9, 2026.
NASDAQ
Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reported a transaction involving the sale of common stock.
NASDAQ
HealthEquity EVP & CFO James M. Lucania reported a sale of 2,839 shares of common stock on July 8, 2026.
NASDAQ
HealthEquity Inc. executive Delano Ladd reported a sale of 1,087 shares of common stock on July 8, 2026, for $95.08 per share.
NASDAQ
HealthEquity, Inc. reports a Form 4 filing detailing stock transactions by President and CEO Scott Cutler.
NASDAQ
Healthequity, Inc. executive Michael Fiore sold 2,045 shares of common stock for $95.0831 per share.
NASDAQ
HealthEquity Inc. executive Michael Fiore reported a transaction involving the sale of common stock, executed under a pre-arranged trading plan.
NASDAQ
HealthEquity, Inc. reports a Form 4 filing detailing William Gassen's acquisition of 2,877 shares of common stock.
NASDAQ
HealthEquity, Inc. Director Rajesh Natarajan acquired 2,877 shares of common stock on June 25, 2026, as reported in a Form 4 filing.
NASDAQ
HealthEquity, Inc. Director Stuart B. Parker acquired 2,877 shares of common stock through restricted stock units.
NASDAQ
HealthEquity Director Gayle Furgurson Wellborn acquired 2,877 shares of common stock.
NASDAQ
HealthEquity, Inc. Director Adrian T. Dillon acquired 2,877 shares of common stock on June 25, 2026.
NASDAQ
Evelyn S. Dilsaver, a Director at HealthEquity, Inc., acquired 2,877 shares of common stock on June 25, 2026.
NASDAQ
HealthEquity, Inc. Director Robert W. Selander acquired 2,877 shares of common stock on June 25, 2026, increasing his beneficial ownership.
NASDAQ
HealthEquity Inc. executive Michael Fiore reported a sale of 3,142 shares of common stock, executed under a pre-arranged 10b5-1 trading plan.
NASDAQ
HealthEquity director Gayle Wellborn exercised options and sold 2,439 shares of common stock under a pre-arranged 10b5-1 plan.
NASDAQ
HealthEquity, Inc. EVP and General Counsel Delano Ladd sold 7,500 shares of common stock via a Rule 10b5-1 trading plan.
NASDAQ
Stephen Neeleman, Founder and Vice Chairman of HealthEquity, Inc., reported a series of transactions involving common stock and stock options.
NASDAQ
HealthEquity Inc. EVP, General Counsel Ladd Delano reported a sale of 2,481 shares of common stock on April 6, 2026.
NASDAQ
Michael Fiore, EVP and Chief Commercial Officer of HealthEquity, Inc., reported a sale of 3,378 shares of common stock.
NASDAQ
HealthEquity, Inc. EVP, Chief Technology Officer Elimelech Rosner reported a sale of 4,768 shares of common stock on April 6, 2026.